NCT00724906View on ClinicalTrials.gov

Two Separate But Identical Studies Evaluating the Safety and Efficacy of ALTROPANE® in the Use of SPECT Imaging for Upper Extremity Tremor

PHASE3UnknownINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Parkinsonian Syndromes
Interventions
DRUG

123 I - ALTROPANE®

8.0 mCi (±1.0 mCi) will be administered intravenously to each subject.

Trial Locations (1)

01748

Alseres Pharmaceuticals, Inc, Hopkinton

Sponsors
All Listed Sponsors
lead

Alseres Pharmaceuticals, Inc

INDUSTRY

NCT00724906 - Two Separate But Identical Studies Evaluating the Safety and Efficacy of ALTROPANE® in the Use of SPECT Imaging for Upper Extremity Tremor | Biotech Hunter | Biotech Hunter